Design Therapeutics, Inc. operates as a biotechnology company that develops therapies for serious degenerative disorders. It is created to design, develop and commercialize a novel class of small molecule therapeutic candidates (GeneTACs) designed to directly address the underlying basis of genetic disease. The company was founded by Pratik Shah and Aseem Z. Ansari on December 18, 2017 and is headquartered in Carlsbad, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
124
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Design Therapeutics Inc market cap is $596.82M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Design Therapeutics Inc 52 week high is $17.25 as of November 20, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Design Therapeutics Inc 52 week low is $7.82 as of November 20, 2026.
Design Therapeutics Inc stock price today is $9.02.
Design Therapeutics Inc stock price yesterday was $9.32.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Design Therapeutics Inc's P/E ratio is -7.74.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Design Therapeutics Inc P/B ratio is 2.9401.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Design Therapeutics Inc 50-day moving average is $11.25.